June 13, 2025

Weight Loss Drugs Show Promise for Heart Failure

ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity.

Conexiant

June 10, 2025

Castor Oil

The ASCO Post’s Integrative Oncology series is intended to facilitate the availability of evidence-based information on integrative and complementary therapies sometimes used by patients with cancer. ...

The ASCO Post

June 02, 2025

Restrictive Platelet Thresholds Endorsed in New Guidelines

International experts reviewed decades of data and endorsed lower platelet transfusion thresholds.

Conexiant

June 01, 2025

Survival of a Maxillary Incisor in an Adolescent Female Patient 10 Years After Delayed Replantation

This case demonstrates that although delayed replantation usually has an unfavorable prognosis, every effort should be made to maintain the natural tooth in place whenever possible.

Compendium

May 30, 2025

Major Medical Societies Issue GLP-1 Nutrition Guidelines

New advisory addresses nutritional challenges and side effects for obesity treatment

Conexiant

May 29, 2025

Mid Atlantic Conference: Concepts in Cardiology 2025

Don’t miss the most comprehensive course designed for cardiology providers, cardiologists,  interventional cardiologists, electrophysiologists, nurses, NPs, PAs, and technologists, and students on strategies for managing cardiovascular care. 

Sentara

May 28, 2025

Stem Cell Transplant May Not Be Necessary in First Remission for Patients With Mantle Cell Lymphoma and Undetectable MRD

Autologous stem cell transplantation (ASCT) does not improve survival outcomes for patients with mantle cell lymphoma who achieve a deep first complete remission with undetectable measurable residual ...

The ASCO Post

May 28, 2025

Statins Recommended for HIV Patients at Risk for Heart Disease

Guidelines from the Department of Health and Human Services recommend statins as primary prevention for people with HIV aged 40 to 75 years who have a 10-year ASCVD risk of 5% or higher.

Conexiant

May 23, 2025

W. Kimryn Rathmell, MD, PhD, FASCO, Named CEO of OSUCCC-James

Following a comprehensive national search, W. Kimryn Rathmell, MD, PhD, FASCO, former Director of the National Cancer Institute (NCI), has accepted the role of Chief Executive Officer (CEO) of The Ohi...

The ASCO Post